Vaxxitek HVT IBD (live vHVT013-69 recombinant virus) – Package leaflet - QI01AD15

Sadržaj članka

PACKAGE LEAFLET FOR:

Vaxxitek HVT+IBD suspension and solvent for suspension for injection

1.NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT

Marketing authorisation holder

MERIAL

29 Avenue Tony Garnier

69007 Lyon, France

Manufacturer responsible for batch release

MERIAL

Laboratory of Lyon Porte des Alpes Rue de l’Aviation,

69800 Saint-Priest France

2.NAME OF THE VETERINARY MEDICINAL PRODUCT

Vaxxitek HVT+IBD Suspension and solvent for suspension for injection

3.STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S)

Each dose of vaccine contains:

 

Active ingredient:

 

Live vHVT013-69 recombinant virus, at least.........................................................

3.6 to 5.0 log10 PFU

Excipient......................................................................................................................................

qs 1 dose

Diluent:

 

Diluent.........................................................................................................................................

qs 1 dose

4.

INDICATION(S)

 

For active immunisation of chickens:

To prevent mortality and to reduce clinical signs and lesions of Infectious Bursal disease. The onset of protection is from 2 weeks and the protection extends to 9 weeks.

To reduce mortality, clinical signs and lesions of Marek’s disease.

The onset of protection is from 4 days. A single vaccination is sufficient to provide protection during the risk period.

5.CONTRAINDICATIONS

Do not use in birds in lay and breeding birds.

6.ADVERSE REACTIONS

None known.

If you notice any serious effects or other effects not mentioned in this package leaflet, please inform your veterinary surgeon.

7.TARGET SPECIES

Day-old chickens and 18 days embryonated eggs.

8.DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION

Subcutaneous or in ovo route.

For in ovo administration, an automated egg injection machine can be used. The device should be proven to safely and effectively deliver the appropriate dose. The instructions for use of this device should be strictly followed.

Subcutaneous route: one single injection of 0.2 ml per chicken at the age of one day.

In ovo route: one single injection of 0.05 ml per egg at 18 days of embryonation.

9.ADVICE ON CORRECT ADMINISTRATION

Wear protective gloves and spectacles during the ampoule thawing and opening operations.

Remove from the liquid nitrogen container only those ampoules which are to be used immediately.

Thaw rapidly the contents of the ampoules by agitation in water at 25°C-30°C. Proceed immediately to next step.

As soon as they are thawed, open ampoules holding them at arm’s length in order to prevent any risk of injury should an ampoule break.

Once the ampoule is opened, draw up the contents into a 5 ml sterile syringe.

Transfer the suspension into the diluent (Do not use if cloudy).

Draw up 2 ml of the contents of the diluent into the syringe.

Rinse the ampoule with these 2 ml and then transfer the rinsing liquid into the diluent. Repeat the rinsing operation once or twice.

Repeat the thawing, opening, transfer and rinsing operations for the appropriate number of ampoules to be reconstituted in the diluent; either 1 ampoule of 1,000 doses of vaccine per 200 ml of diluent (or 1 ampoule of 2,000 doses of vaccine per 400 ml of diluent) for subcutaneous administration, or 4 ampoules of 1,000 doses of vaccine per 200 ml of diluent (or 4 ampoules of 2,000 doses of vaccine per 400 ml of diluent) for in ovo administration.

The diluted vaccine prepared as described is mixed by gentle agitation so as to be ready for use. It should be used immediately after the preparation (all of the diluted vaccine should be used up within one hour). This is why the vaccine suspension should only be prepared as and when required

10.WITHDRAWAL PERIOD

Zero days.

11.SPECIAL STORAGE PRECAUTIONS

Keep out of the sight and reach of children.

Store the vaccine in liquid nitrogen.

Do not use after the expiry date stated on the ampoule.

Shelf life of the reconstituted vaccine: up to 2 hours at a temperature below 25°C.

12.SPECIAL WARNING(S)

Special precautions for use in animals: Vaccinate only healthy birds.

Apply the usual aseptic precautions to all administration procedures.

As a live vaccine, the vaccine strain is excreted from vaccinated birds and may spread to turkeys. Safety and reversion to virulence trials have shown that the strain is safe for turkeys. However, precautionary measures have to be followed in order to avoid direct or indirect contact between vaccinated chickens and turkeys.

Special precautions to be taken by the person administering the veterinary medicinal product to animals:

Wear protective gloves and spectacles during the ampoule thawing and opening operations.

Open ampoules holding them at arm’s length in order to prevent any risk of injury should an ampoule break.

Lay:

Do not use in breeding birds and birds in lay.

Interaction with other medicinal products and other forms of interaction: For subcutaneous route:

Safety and efficacy data are available which demonstrate that this vaccine can be mixed with Merial attenuated vaccines against Marek’s disease Rispens strain.

Safety and efficacy data are available which demonstrate that this vaccine can be administered on the same day but not mixed with Merial attenuated vaccines against Newcastle disease and Infectious bronchitis.

No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product except the products mentioned above. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.

For in ovo route:

In the absence of specific studies, no other veterinary medicinal product should be administered concurrently with the product.

Use sterile and antiseptic-free and/or disinfectant-free equipment for injections purposes. Do not mix with any other veterinary medicinal product except those mentioned in the above paragraph and the diluent supplied for use with the product.

13.SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS, IF ANY

Discard any ampoules that have been accidentally thawed. Do not re-freeze under any circumstances. Do not re-use opened containers of diluted vaccine.

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

14.DATE ON WHICH THE PACKAGE LEAFLET WAS LAST APPROVED

Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu/.

15.OTHER INFORMATION

Live recombinant vaccine against Infectious Bursal Disease and Marek’s Disease.

The vaccine strain is a recombinant Herpesvirus of turkeys (HVT) expressing the protective antigen (VP2) of the Infectious Bursal Disease Virus (IBDV) strain Faragher 52/70.

The vaccine induces an active immunity and a serological response against Infectious Bursal Disease and Marek’s Disease in chickens.

-(glass) ampoule of 1,000 doses of vaccine, 5-ampoule carrier.

-(glass) ampoule of 2,000 doses of vaccine, 4-ampoule carrier.

Ampoule carriers are stored in canister, and in liquid nitrogen containers.

-(polypropylene) bottle of 200ml of diluent.

-(polyvinylchloride) bag of 200ml, 400ml, 600ml, 800ml, 1000ml, 1200ml, 1400ml, 1600ml, 1800ml or 2400ml of diluent

Not all pack sizes may be marketed.

Veterinary medicinal product subject to prescription.

PACKAGE LEAFLET FOR

STERILE DILUENT

1.NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT

Marketing authorisation holder:

MERIAL

29 avenue Tony Garnier

69007 Lyon, France

Manufacturer responsible for batch release:

MERIAL

Laboratory of Lyon Porte des Alpes Rue de l’Aviation,

69800 Saint-Priest France

2.NAME OF THE VETERINARY MEDICINAL PRODUCT

STERILE DILUENT

3.ADVERSE REACTIONS

None known.

If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon.

4.TARGET SPECIES

Chickens.

5.DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION

Read the package leaflet supplied with the vaccine vial.

6. ADVICE ON CORRECT ADMINISTRATION

Frozen vaccines:

Wear protective gloves and spectacles during the ampoule thawing and opening operations.

Remove from the liquid nitrogen container only those ampoules which are to be used immediately.

Thaw rapidly the contents of the ampoules by agitation in water at 25°C-30°C. Proceed immediately to next step.

As soon as they are thawed, open ampoules holding them at arm’s length in order to prevent any risk of injury should an ampoule break.

Once the ampoule is opened, draw up the contents into a 5 ml sterile syringe.

Transfer the suspension into the diluent.

Draw up 2 ml of the contents of the diluent into the syringe.

Rinse the ampoule with these 2 ml and then transfer the rinsing liquid into the diluent. Repeat the rinsing operation once or twice.

Repeat the thawing, opening, transfer and rinsing operations for the appropriate number of ampoules to be reconstituted in the diluent; either 1 ampoule of 1,000 doses of vaccine per 200 ml of diluent (or 1 ampoule of 2,000 doses of vaccine per 400 ml of diluent) for subcutaneous administration, or 4 ampoules of 1,000 doses of vaccine per 200 ml of diluent (or 4 ampoules of 2,000 doses of vaccine per 400 ml of diluent) for in ovo administration.

The diluted vaccine prepared as described is mixed by gentle agitation so as to be ready for use. It should be used immediately after the preparation (all of the diluted vaccine should be used up within one hour). This is why the vaccine suspension should only be prepared as and when required.

7.WITHDRAWAL PERIOD

Zero days.

8.SPECIAL STORAGE PRECAUTIONS

Keep out of the sight and reach of children.

Store below 30°C. Do not freeze.

9.SPECIAL WARNING(S)

Use immediately after preparation.

Do not use if cloudy.

10.SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS, IF ANY

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

11.DATE ON WHICH THE PACKAGE LEAFLET WAS LAST APPROVED

Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu/.

12.OTHER INFORMATION

This diluent may be used with the following products:

Vaxxitek HVT+IBD (EU/2/02/032/001-002)

Komentari